MediciNova receives notice of Japanese patent allowance for ibudilast
MN-166 is used for certain neurological conditions, including progressive forms of multiple sclerosis, neuropathic pain, and drug addiction. The patent once received is expected to expire by the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.